Critical Care News

Neurological manifestations occurred frequently in patients hospitalized with COVID-19 and correlated with increased in-hospital mortality, according to findings from a multicohort study published in JAMA Network Open.

Patients with atypical MI symptoms were less likely to receive emergency help and had greater risk for dying within 30 days compared with those with chest pain, researchers reported.

Intracerebral hemorrhage correlated with an increased risk for ischemic stroke and myocardial infarction, according to results from an analysis of four population-based, U.S. cohort studies that was published in JAMA Neurology.

Delays in care after acute ischemic stroke correlated with loss of healthy life-years among patients treated with endovascular thrombectomy, especially in the post-arrival period, according to findings published in JAMA Neurology.

This week, the question of whether we’ll need COVID-19 booster shots; the ACIP recommends resuming use of the J&J COVID-19 vaccine; humans in the UK transmitted SARS-CoV-2 to their cats; an NBA study shows that persistent positive cases do not transmit COVID-19 after recovery; and neurological symptoms with COVID-19 serve as an ‘important predictor’ of poor outcomes.

Neighborhood socioeconomic status significantly influenced recovery outcomes following a stroke, particularly a moderate to severe stroke, according to a population-based surveillance study published in Neurology.

Viral RNA load was low and did not appear associated with other pathological features among a small cohort of fatal COVID-19 cases, according to study results presented during the American Academy of Neurology annual meeting.

Patients with COVID-19 and certain neurological problems had longer hospital lengths of stay and higher in-hospital mortality, among other adverse outcomes, according to findings from a prospective cohort study of 211 hospitalized patients.

Stroke burden varied by racial/ethnic groups, with higher adjusted prevalence and incidence among Black participants compared with white participants, according to findings from a cross-sectional cohort study of more than 220,000 patients.

Race, ethnicity and health insurance status all appeared to impact receipt of treatment for ischemic stroke among patients in California, Florida and New York, according to a retrospective analysis of more than 1 million hospitalizations.